Table 3.
Critical appraisal via overall NOQAT Evaluation for both safety and efficacy, and oncological outcomes for included studies.
| Author | n = | Overall NOQAT evaluation across both investigated outcomes | |
|---|---|---|---|
| Safety and efficacy | Oncological outcomes | ||
| Thomson et al. 14 | 7 | Poor | Poor |
| Pech et al. 15 | 6 | Good | – |
| Diehl et al. 16 | 5 | Good | Fair |
| Vroomen et al. 17 | 1 | Fair | Poor |
| Canvasser et al. 18 | 41 | Good | Fair |
| Liu et al. 19 | 5 | Fair | Fair |
| Wendler et al. 20 | 7 | Good | Good |
| Wendler et al. 21 | As above | Good | – |
| Buijs et al. 22 | 10 | Good | – |
| Gul et al. 23 | 1 | Fair | Fair |